Feasibility of Exercise and Transcranial Direct Current Stimulation for the Treatment of Post-traumatic Headache
Public ClinicalTrials.gov record NCT07928492. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Imaging Markers of Central and Peripheral Impairment in Chronic Post-Traumatic Headache
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The goal of this prospective case series is to assess the feasibility of intervention and assessment protocols for telehealth intervention with mindfulness-based exercise, transcranial direct current stimulation, and their combination in Veterans with peristent post-traumatic headache. The main questions it aims to answer are: What percentage of patients complete pre- and post- assessment measures? Are patients adherent to and satisfied with each intervention? What are potential adverse effects of treatment? How responsive are patient-reported outcome measures and biomarkers of brain connectivity, muscle health, and pain sensitivity to change following treatment? Participants will complete 18 telehealth sessions with a physical therapist (3x/wk for 6 weeks) with one of the following interventions: 1. mindfulness-based cervicoscapular exercise 2. transcranial direct current stimulation (tDCS) over the motor cortex 3. combined treatment with exercise and tDCS Participants will complete the following assessments before and after intervention: 1. magnetic resonance imaging (MRI) of the brain 2. MRI of neck muscles 3. quantitative sensory testing of pain sensitivity 4. health questionnaires
Study identification
- NCT ID
- NCT07928492
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 1
- Enrollment
- 18 participants
Conditions and interventions
Conditions
Interventions
- Exercise Behavioral
- transcranial direct current stimulation Device
Behavioral · Device
Eligibility (public fields only)
- Age range
- 18 Years to 60 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 1, 2021 (Actual)
- Primary completion
- Oct 14, 2022 (Actual)
- Completion
- Oct 14, 2022 (Actual)
- Last update posted
- Nov 10, 2026
2021 – 2022
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| VA San Diego Healthcare System | San Diego | California | 92161 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07928492, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 10, 2026 · Synced Nov 10, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT07928492 live on ClinicalTrials.gov.